The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

Craig Campbell

craig-campbell

Investigator

Head of the Division of Pediatric Neurology and acting chair of the Department of Pediatrics

Professor of Pediatrics, Epidemiology and Clinical Neurological Sciences, Western University


NMD4C Working Group(s): Clinical Trial Coordination

Email Craig

Biography

Dr. Craig Campbell is the acting chair of Pediatrics (Research), the Head of the Division of Pediatric Neurology and the medical director of the multidisciplinary neuromuscular clinic based at Thames Valley Children’s Centre and the Pediatric Neurophysiology Laboratory at Children’s Hospital London Health Sciences Centre. He is a Full Professor in Pediatrics, Clinical Neurological Sciences and Epidemiology at Western University and a Scientist at the Children’s Health Research Institute. His training in pediatrics, neurology and epidemiology was completed at the University of Ottawa.

Dr. Campbell is collaboratively involved in many academic and industry initiated clinical trial activities in pediatric neuromuscular disease. He is a member of the Muscle Study Group and the World Muscle Society, and co-chair of the TREAT-NMD Registry Oversight Committee and Task Force. Dr. Campbell has been awarded the George Karpati Award Researcher of the Year in 2011 and 2015 by Muscular Dystrophy Canada.

As part of NMD4C Dr. Campbell is implementing innovations for the Canadian Neuromuscular Disease Registry that facilitate data sharing and patient engagement. He will also be developing a research curriculum and clinical trial network.


Recent Publications

Statland, JM, Campbell, C, Desai, U, Karam, C, Díaz-Manera, J, Guptill, JT et al.. Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy. Muscle Nerve. 2022. PMID:35428982

Guglieri, M, Bushby, K, McDermott, MP, Hart, KA, Tawil, R, Martens, WB et al.. Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial. JAMA. 2022.327 (15)1456-1468 PMID:35381069

Katz, SL, Mah, JK, McMillan, HJ, Campbell, C, Bijelić, V, Barrowman, N et al.. Routine lung volume recruitment in boys with Duchenne muscular dystrophy: a randomised clinical trial. Thorax. 2022. PMID:35236763

Rudnicki, SA, Andrews, JA, Duong, T, Cockroft, BM, Malik, FI, Meng, L et al.. Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study. Neurotherapeutics. 2021.18 (3)2130 PMID:34731415

Shieh, PB, Elfring, G, Trifillis, P, Santos, C, Peltz, SW, Parsons, JA et al.. Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy. J Comp Eff Res. 2021.10 (18)1337-1347 PMID:34693725

See more on PubMed